{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:01:43Z","timestamp":1790708503606,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.neuro.2009.06.009","type":"journal-article","created":{"date-parts":[[2009,7,3]],"date-time":"2009-07-03T05:07:13Z","timestamp":1246597633000},"page":"1127-1132","source":"Crossref","is-referenced-by-count":166,"title":["Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: A biological link between Gaucher disease and parkinsonism"],"prefix":"10.1016","volume":"30","author":[{"given":"Amy B.","family":"Manning-Bo\u011f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitt","family":"Sch\u00fcle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. William","family":"Langston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2009.06.009_bib1","first-page":"255","article-title":"Gaucher disease in mice induced by conduritol-B-epoxide: morphologic features","volume":"101","author":"Adachi","year":"1977","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.neuro.2009.06.009_bib2","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1212\/01.wnl.0000176987.47875.28","article-title":"Mutations in the glucocerebrosidase gene and Parkinson disease: phenotype\u2013genotype correlation","volume":"65","author":"Aharon-Peretz","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2009.06.009_bib3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10038-007-0135-4","article-title":"Mutation analysis and genotype\/phenotype relationships of Gaucher disease patients in Spain","volume":"52","author":"Alfonso","year":"2007","journal-title":"J Hum Genet"},{"key":"10.1016\/j.neuro.2009.06.009_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.WNL.0000072482.70963.D7","article-title":"Gaucher's disease with Parkinson's disease: clinical and pathological aspects","volume":"61","author":"Bembi","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2009.06.009_bib5","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.12.003","article-title":"Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system","volume":"22","author":"Betarbet","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuro.2009.06.009_bib6","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuro.2009.06.009_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/08035320600619039","article-title":"Gaucher disease: multiple lessons from a single gene disorder","volume":"95","author":"Beutler","year":"2006","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.neuro.2009.06.009_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s004010000247","article-title":"Alpha-synuclein immunopositive Parkinson's disease-related inclusion bodies in lower brain stem nuclei","volume":"101","author":"Braak","year":"2001","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuro.2009.06.009_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00401-007-0244-3","article-title":"Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease","volume":"114","author":"Braak","year":"2007","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuro.2009.06.009_bib10","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","article-title":"A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"80","author":"Burns","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neuro.2009.06.009_bib11","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.cbpa.2007.05.035","article-title":"Gaucher disease","volume":"11","author":"Butters","year":"2007","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.neuro.2009.06.009_bib12","first-page":"310","article-title":"Light microscopic and ultrastructural study on CNS lesions in infantile Gaucher's disease","volume":"9","author":"Cervos-Navarro","year":"1990","journal-title":"Clin Neuropathol"},{"key":"10.1016\/j.neuro.2009.06.009_bib13","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"Alpha-synuclein locus duplication as a cause of familial Parkinson's disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.neuro.2009.06.009_bib14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bcmd.2006.11.003","article-title":"Gaucher disease among Chinese patients: review on genotype\/phenotype correlation from 29 patients and identification of novel and rare alleles","volume":"38","author":"Choy","year":"2007","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.neuro.2009.06.009_bib15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/mds.20320","article-title":"Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity","volume":"20","author":"Clark","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuro.2009.06.009_bib16","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00401-006-0119-z","article-title":"Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration","volume":"112","author":"Croisier","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuro.2009.06.009_bib17","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ana.10846","article-title":"Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications","volume":"55","author":"Farrer","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuro.2009.06.009_bib18","doi-asserted-by":"crossref","first-page":"6715","DOI":"10.1523\/JNEUROSCI.1594-04.2004","article-title":"Lipid rafts mediate the synaptic localization of alpha-synuclein","volume":"24","author":"Fortin","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2009.06.009_bib19","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1212\/01.wnl.0000254458.17630.c5","article-title":"Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication","volume":"68","author":"Fuchs","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2009.06.009_bib20","doi-asserted-by":"crossref","first-page":"8465","DOI":"10.1021\/bi0341152","article-title":"Nuclear localization of alpha-synuclein and its interaction with histones","volume":"42","author":"Goers","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuro.2009.06.009_bib21","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/jmg.2004.024455","article-title":"Parkinsonism among Gaucher disease carriers","volume":"41","author":"Goker-Alpan","year":"2004","journal-title":"J Med Genet"},{"key":"10.1016\/j.neuro.2009.06.009_bib22","doi-asserted-by":"crossref","first-page":"48984","DOI":"10.1074\/jbc.M208194200","article-title":"Golgi fragmentation occurs in the cells with prefibrillar alpha-synuclein aggregates and precedes the formation of fibrillar inclusion","volume":"277","author":"Gosavi","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuro.2009.06.009_bib23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/gte.1997.1.5","article-title":"Gaucher disease: gene frequencies and genotype\/phenotype correlations","volume":"1","author":"Grabowski","year":"1997","journal-title":"Genet Test"},{"key":"10.1016\/j.neuro.2009.06.009_bib24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00431-003-1362-0","article-title":"Pediatric non-neuronopathic Gaucher disease: presentation, diagnosis and assessment, Consensus statements","volume":"163","author":"Grabowski","year":"2004","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.neuro.2009.06.009_bib25","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jbspin.2007.06.006","article-title":"Gaucher disease","volume":"75","author":"Guggenbuhl","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.neuro.2009.06.009_bib26","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.expneurol.2006.12.020","article-title":"Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system","volume":"204","author":"Hatcher","year":"2007","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuro.2009.06.009_bib27","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.6610213","article-title":"Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice","volume":"224","author":"Heikkila","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.neuro.2009.06.009_bib28","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/(SICI)1098-1004(1998)12:4<240::AID-HUMU4>3.0.CO;2-J","article-title":"Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population","volume":"12","author":"Horowitz","year":"1998","journal-title":"Hum Mutat"},{"key":"10.1016\/j.neuro.2009.06.009_bib29","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20676","article-title":"Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)","volume":"29","author":"Hruska","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.neuro.2009.06.009_bib30","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2141.2004.05351.x","article-title":"Gaucher disease: pathological mechanisms and modern management","volume":"129","author":"Jmoudiak","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.neuro.2009.06.009_bib31","doi-asserted-by":"crossref","first-page":"15240","DOI":"10.1074\/jbc.M312497200","article-title":"Alpha-synuclein up-regulation and aggregation during MPP+-induced apoptosis in neuroblastoma cells: intermediacy of transferrin receptor iron and hydrogen peroxide","volume":"279","author":"Kalivendi","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuro.2009.06.009_bib32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0006-291X(75)90286-7","article-title":"The Gaucher mouse","volume":"67","author":"Kanfer","year":"1975","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neuro.2009.06.009_bib33","first-page":"627","article-title":"The Gaucher mouse","volume":"95","author":"Kanfer","year":"1982","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.neuro.2009.06.009_bib34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jns.2006.10.019","article-title":"Dopaminergic neuronal dysfunction associated with parkinsonism in both a Gaucher disease patient and a carrier","volume":"252","author":"Kono","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuro.2009.06.009_bib35","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0006-8993(84)90777-7","article-title":"Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey","volume":"292","author":"Langston","year":"1984","journal-title":"Brain Res"},{"key":"10.1016\/j.neuro.2009.06.009_bib36","first-page":"49","article-title":"MPTP-induced parkinsonism in human and non-human primates\u2014clinical and experimental aspects","volume":"100","author":"Langston","year":"1984","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1016\/j.neuro.2009.06.009_bib37","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1523\/JNEUROSCI.3809-03.2004","article-title":"Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway","volume":"24","author":"Lee","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2009.06.009_bib38","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.biocel.2008.01.017","article-title":"Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein","volume":"40","author":"Lee","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.neuro.2009.06.009_bib39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12031-007-0012-9","article-title":"Origins and effects of extracellular alpha-synuclein: implications in Parkinson's disease","volume":"34","author":"Lee","year":"2008","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.neuro.2009.06.009_bib40","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ymgme.2003.11.004","article-title":"Glucocerebrosidase mutations in subjects with parkinsonism","volume":"81","author":"Lwin","year":"2004","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.neuro.2009.06.009_bib41","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/(SICI)1096-8652(199907)61:3<216::AID-AJH12>3.0.CO;2-B","article-title":"Parkinson's syndrome preceding clinical manifestation of Gaucher's disease","volume":"61","author":"Machaczka","year":"1999","journal-title":"Am J Haematol"},{"key":"10.1016\/j.neuro.2009.06.009_bib42","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1074\/jbc.C100560200","article-title":"The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein","volume":"277","author":"Manning-Bo\u011f","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuro.2009.06.009_bib43","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1523\/JNEUROSCI.23-08-03095.2003","article-title":"Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration","volume":"23","author":"Manning-Bo\u011f","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2009.06.009_bib44","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/nbdi.2002.0507","article-title":"Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat","volume":"10","author":"McCormack","year":"2002","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuro.2009.06.009_bib45","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0006-8993(02)03514-X","article-title":"Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease","volume":"956","author":"Meredith","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.neuro.2009.06.009_bib46","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/qjmed\/89.9.691","article-title":"Occurrence of Parkinson's syndrome in type I Gaucher disease","volume":"89","author":"Neudorfer","year":"1996","journal-title":"Qjm"},{"key":"10.1016\/j.neuro.2009.06.009_bib47","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0045-6039(84)90038-1","article-title":"Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiation","volume":"14","author":"Pahlman","year":"1984","journal-title":"Cell Differ"},{"key":"10.1016\/j.neuro.2009.06.009_bib48","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0950-3536(97)80037-6","article-title":"Gaucher's Disease. Pathological features","volume":"10","author":"Pastores","year":"1997","journal-title":"Baillieres Clin Haematol"},{"key":"10.1016\/j.neuro.2009.06.009_bib49","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.nbd.2005.05.028","article-title":"Alpha-synuclein expression in the substantia nigra of MPTP-lesioned non-human primates","volume":"20","author":"Purisai","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuro.2009.06.009_bib50","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/ng1591","article-title":"Dynein mutations impair autophagic clearance of aggregate-prone proteins","volume":"37","author":"Ravikumar","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.neuro.2009.06.009_bib51","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/mds.20319","article-title":"Analysis of the glucocerebrosidase gene in Parkinson's disease","volume":"20","author":"Sato","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuro.2009.06.009_bib52","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1056\/NEJM200502173520719","article-title":"The glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews","volume":"352","author":"Schlossmacher","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuro.2009.06.009_bib53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/exnr.2002.8072","article-title":"Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation","volume":"179","author":"Sherer","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuro.2009.06.009_bib54","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1399-0004.2006.00688.x","article-title":"Heterozygosity for a Mendelian disorder as a risk factor for complex disease","volume":"70","author":"Sidransky","year":"2006","journal-title":"Clin Genet"},{"key":"10.1016\/j.neuro.2009.06.009_bib55","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"alpha-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuro.2009.06.009_bib56","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1097\/00001756-200107030-00028","article-title":"Expression of alpha-synuclein in a human glioma cell line and its up-regulation by interleukin-1beta","volume":"12","author":"Tanji","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuro.2009.06.009_bib57","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/mgme.2001.3201","article-title":"Gaucher disease and parkinsonism: a phenotypic and genotypic characterization","volume":"73","author":"Tayebi","year":"2001","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.neuro.2009.06.009_bib58","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1096-7192(03)00071-4","article-title":"Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?","volume":"79","author":"Tayebi","year":"2003","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.neuro.2009.06.009_bib59","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1163\/15685590260461084","article-title":"Gaucher disease type I complicated with Parkinson's syndrome","volume":"32","author":"Varkonyi","year":"2002","journal-title":"Haematologia (Budap)"},{"key":"10.1016\/j.neuro.2009.06.009_bib60","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1471-4159.2000.740721.x","article-title":"Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP","volume":"74","author":"Vila","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2009.06.009_bib61","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/archinternmed.2007.128","article-title":"Prevalence of type 1 Gaucher disease in the United States","volume":"168","author":"Weinreb","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.neuro.2009.06.009_bib62","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00003727-200701000-00007","article-title":"Selected genetic disorders affecting Ashkenazi Jewish families","volume":"30","author":"Weinstein","year":"2007","journal-title":"Fam Community Health"},{"key":"10.1016\/j.neuro.2009.06.009_bib63","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","article-title":"Neuropathology provides clues to the pathophysiology of Gaucher disease","volume":"82","author":"Wong","year":"2004","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.neuro.2009.06.009_bib64","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1056\/NEJM200502173520719","article-title":"The glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews","volume":"352","author":"Zimran","year":"2005","journal-title":"N Engl J Med"}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X09001302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X09001302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T02:26:01Z","timestamp":1589941561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X09001302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0161813X09001302"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2009.06.009","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}